Cost-effectiveness Analysis of Three Corticosteroids in ILDs

NCT04982809 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

107

Enrollment

OTHER

Sponsor class

Conditions

Interstitial Lung Disease

Interventions

DRUG: Betamethasone, Dexamethasone, Prednisolone

Sponsor

Cairo University